RHEA Score
  • HOME
  • ESTIMATION
  • ABOUT

Welcome to RHEA


Right heart failure (RHF) is a global pandemic secondary to a myriad of conditions with poor prognosis. Early identification of RHF among high-risk populations could facilitate closer clinical surveillance and prompt timely aggressive interventions, ultimately improving clinical outcomes. To explore the clinical characteristics and outcomes of patients with RHF, the Right HEart fAilure (RHEA) cohort has been established and registered on ClinicalTrials.gov (NCT 06023134).

What is RHEA Score

RHEA Score (Right HEart fAilure ) is an easy-to-use screening model. It simplifies the assessment of RHF likelihood and aids in identifying RHF among high-risk pulmonary hypertension (PH) patients, especially in low-resource settings. At present, this tool may be used for educational and research purposes only.

Evidence

RHEA Score is proposed for the discrimination of RHF from PH. The score is derived from the data of RHEA cohort which contains a total of 802 RHF patients, PH patients and normal controls confirmed by right heart catheterization and echocardiography from 32 provinces, municipalities, and autonomous regions in China. A machine learning approach was applied solely using multiple biomarkers to establish this user-friendly novel model to distinguish RHF from at-risk patients. Only 5 predictors including NT-proBNP, GGT, RDW, AGE and NSE, are needed.

Cite us!

Identifying right heart failure patients from at-risk individuals using machine learning approaches: Insights from the Right HEart fAilure (RHEA) study. 2024 (unpublished)


Contact: renjingyi1213@hotmail.com; yangjuntao@gmail.com

RHEA Score Estimation

RHEA score is for illustrative purpose only and should not be used for diagnostic or treatment purposes. Further studies have been working on the perfection of the novel model.

  • When to Use
  • Why Use

Use in patients with clinical manifestations similar to RHF who are PH and at risk of progressing to RHF, to assess the probability of developing RHF.

RHF is difficult to discriminate especially in specific settings such as primary care and emergency department.

This score offers an evidence-based way to identify patients likely to have RHF.


  • Manual Input
  • Batch Input





Example File



NOTE


NT-proBNP

N-terminal pro-B-type natriuretic peptide

GGT

γ-glutamyl transpeptidase

RDW

red blood cell distribution width

AGE

age, years old

NSE

neuron-specific enolase

RHF

right heart failure

PH

pulmonary hypertension


Cite us!

Identifying right heart failure patients from at-risk individuals using machine learning approaches: Insights from the Right HEart fAilure (RHEA) study. 2024 (unpublished)


Contact: renjingyi1213@hotmail.com; yangjuntao@gmail.com

About RHEA Score

RHEA Score is derived from the data of RHEA cohort and proposed for the discrimination of RHF from PH. The cohort contains a total of 802 RHF patients, PH patients and normal controls confirmed by right heart catheterization and echocardiography from 32 provinces and areas in China. RHEA Score was developed with a machine learning approach relying on available biomarkers. To get the probability of RHF, only 5 predictors including NT-proBNP, GGT, RDW, AGE and NSE, are needed.

Funding

This work was supported by grants from National High Level Hospital Clinical Research Funding (NO. 2023-NHLHCRF-YYPPLC-ZR-05, NO. 2022-NHLHCRF-YXHZ-01, NO. 2022-NHLHCRF-LX-02-0102, 2024-NHLHCRF-PYII-15), National Science and Technology Major Project (2023ZD0502805), Capital’s Funds for Health Improvement and Research (NO. 2024-1-4061), Beijing Nova Program (NO. 20220484171), and National Natural Science Foundation of China.

Copyright

The content of the web (including, but not limited to all content, design, appearance and graphics) is protected by copyright. The copyright is owned by the Heart Failure Center of China-Japan Friendship Hospital and Peking Union Medical College. Reproduction is prohibited.

Disclaimer

Please ensure to regularly review the website and its contents, as we reserve the right to update them at any moment without prior notice. By continuing to use the web application subsequent to any updates to the terms and conditions, you signify your acceptance of all modifications.



Cite us!

Identifying right heart failure patients from at-risk individuals using machine learning approaches: Insights from the Right HEart fAilure (RHEA) study. 2024 (unpublished)


Contact: renjingyi1213@hotmail.com; yangjuntao@gmail.com